Neurology
Oligonucleotide-based microarrays characterize the gene profile of brain tumors
Published in Gene Therapy Weekly, October 16th, 2003
"Diffuse astrocytoma of World Health Organization (WHO) grade H has an inherent tendency to spontaneously progress to anaplastic astrocytoma (WHO, grade in) and/or glioblastoma (WHO grade IV). The molecular basis of astrocytoma progression is still poorly understood, in particular with respect to the progression-associated changes at the mRNA level.
"Therefore, we compared the transcriptional profile of approximately 6800 genes in primary WHO grade H gliomas and corresponding recurrent high-grade (WHO grade III or IV) gliomas from eight patients using...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-10-16)
More Articles from Gene Therapy Weekly
- Head and Neck Cancer
Liposomal conjugation improves adenoviral transduction of squamous cell cancer - Oncology
Nonradioactive iodide stimulates apoptosis in genetically modified cancer cells - Endocrinology
Excess Bcl-2 production reverses programmed cell death in beta cells - Neuroscience
Gene-modified cells correct Parkinson-like disease in animal models - Oncology
Gene expression mechanisms enhance magnetic resonance images of prostate cancer - Orthopedics
Bone morphogenetic protein-4 gene therapy regenerates in vivo bone formation - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
